Estrella Immunopharma Warrant
ESLAW
13 hedge funds and large institutions have $296K invested in Estrella Immunopharma Warrant in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
21% more capital invested
Capital invested by funds: $244K → $296K (+$51.4K)
0.51% more ownership
Funds ownership: 1.71% → 2.22% (+0.51%)
7% less funds holding
Funds holding: 14 → 13 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ASM
ATW SPAC Management
New York
|
+$14.8K |
| 2 |
CAC
Cowen and Company
New York
|
+$795 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$183 |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$114 |
| 3 |
CS
Clear Street
New York
|
-$8 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$3 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $220K | – | – | – |
|
|
HCM
2
Highbridge Capital Management
New York
| $26.8K | – | – | – |
|
|
ASM
3
ATW SPAC Management
New York
| $16.2K | +$14.8K | +183,099 | New |
|
4
D.E. Shaw & Co
New York
| $6.13K | – | – | – |
|
|
SIA
5
SkyView Investment Advisors
Shrewsbury,
New Jersey
| $6K | – | – | – |
|
6
Walleye Capital
New York
| $4.63K | – | – | – |
|
|
YCM
7
Yakira Capital Management
Westport,
Connecticut
| $4.11K | – | – | – |
|
|
WA
8
Whitebox Advisors
Minneapolis,
Minnesota
| $2.92K | – | – | – |
|
9
Walleye Trading
New York
| $2.6K | – | – | – |
|
|
CAC
10
Cowen and Company
New York
| $2.29K | +$795 | +9,800 | +38% |
|
|
CS
11
Clear Street
New York
| $1.84K | -$8 | -100 | -0.3% |
|
|
LCM
12
Landscape Capital Management
Englewood,
New Jersey
| $880 | – | – | – |
|
|
RCM
13
Robinson Capital Management
Grosse Pointe Farms,
Michigan
| $759 | – | – | – |
|
|
WAM
14
Wolverine Asset Management
Chicago,
Illinois
| $276 | -$114 | -1,400 | -25% |
|
|
15
UBS Group
Zurich,
Switzerland
| – | -$183 | -5,090 | Closed |
|
|
16
Bank of America
Charlotte,
North Carolina
| – | -$3 | -80 | Closed |
|
ESLAW Hedge Fund Activity: Q3 2024 in Review
13 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma Warrant (ESLAW) for Q3 2024, worth a combined $296K — up 21% from $244K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ESLAW and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was ATW SPAC Management, opening a new position worth an estimated $14.8K. The largest seller was UBS Group, exiting entirely with an estimated $183 sold.
- 13 institutional investors held Estrella Immunopharma Warrant (ESLAW) as of Q3 2024, down from 14 in Q2 2024.
- Funds reported $296K of Estrella Immunopharma Warrant stock for Q3 2024, up 21% quarter-over-quarter.
- 1 fund opened new Estrella Immunopharma Warrant positions in Q3 2024 and 2 closed out, a net change of -1 holder.
- The largest Estrella Immunopharma Warrant buyer in Q3 2024 was ATW SPAC Management, an estimated $14.8K added.
- The largest Estrella Immunopharma Warrant seller in Q3 2024 was UBS Group, an estimated $183 sold.
Based on aggregated 13F filings for Q3 2024.